First Time Loading...

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 3.75 GBX -2.6%
Updated: Mar 29, 2024

Fusion Antibodies PLC
Revenue

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Fusion Antibodies PLC
Revenue Peer Comparison

Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Fusion Antibodies PLC
LSE:FAB
Revenue
£1.6m
CAGR 3-Years
-27%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Oxford Nanopore Technologies PLC
LSE:ONT
Revenue
£169.7m
CAGR 3-Years
14%
CAGR 5-Years
39%
CAGR 10-Years
N/A
O
Open Orphan PLC
LSE:ORPH
Revenue
£48.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Revenue
£19.5m
CAGR 3-Years
13%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Revenue
£152.1m
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Revenue
£57.8m
CAGR 3-Years
77%
CAGR 5-Years
32%
CAGR 10-Years
36%

See Also

What is Fusion Antibodies PLC's Revenue?
Revenue
1.6m GBP

Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Revenue amounts to 1.6m GBP.

What is Fusion Antibodies PLC's Revenue growth rate?
Revenue CAGR 5Y
-4%

Over the last year, the Revenue growth was -63%. The average annual Revenue growth rates for Fusion Antibodies PLC have been -27% over the past three years , -4% over the past five years .